SCIENMAG: Medicine & Health

JUNE 21, 2023

This year’s SEB conference will feature over 800 talks covering the latest advances in experimental research across animal, plant and cell biology including impactful research in the fields of wildlife conservation, human disease and bio-inspired robotics, amongst many more.

Cell Biology 91

Cell Biology Disease Research 91

SCIENMAG: Medicine & Health

AUGUST 30, 2023

The discovery is a significant advance in cell biology, likely solves a long-standing mystery about an unusual feature of some ion channels […]

Cell Biology 83

Cell Biology Drugs Research 83

Drug Discovery World

AUGUST 11, 2023

When the researchers performed genetic screens on human melanoma cells to identify genes that contribute to ferroptosis, they found that VKORC1L1 is a potent inhibitor of ferroptosis.

Cell Biology 130

Cell Biology Drugs Regulations FDA 130

SCIENMAG: Medicine & Health

JULY 13, 2023

RESEARCH REVEALS HOW COVID-19 VIRUS INFECTS THE PLACENTA, AND HOW THIS CAN BE PREVENTED Credit: Monash University RESEARCH REVEALS HOW COVID-19 VIRUS INFECTS THE PLACENTA, AND HOW THIS CAN BE PREVENTED In a landmark study published in Nature Cell Biology, Australian researchers, led by Professor Jose Polo from Monash University and the University of (..)

Cell Biology 77

Cell Biology Virus Research 77

Chemical Biology and Drug Design

JULY 26, 2023

lncRNA, miRNA, siRNA, receptors, and proteins) are added to exosomes which are released from the parental cells. Abstract Noncoding RNAs (ncRNAs) are engaged in key cell biological and pathological events, and their expression alteration is connected to cancer progression both directly and indirectly.

Engineering 100

Engineering Therapies Cell Biology Drugs 100

Chemical Biology and Drug Design

JANUARY 5, 2024

After the corresponding transfection or treatment with inhibitor of catenin-responsive transcription-3 (iCRT-3), abovementioned CRC cell biological behaviors as well as expression levels of HOXB7 and β-catenin were evaluated. μM THA dwindled CRC cell viability, migration, and invasion, and facilitated apoptosis.

Bioinformatics 100

Bioinformatics Cell Biology Treatment Research 100

Drug Target Review

JULY 13, 2023

The aim is to establish condensate biology as a fundamental branch of cell biology – “cell biology 2.0” The underlying biology and processes upon which the company was founded have broad applicability across various human disease areas. Klein notes the importance of Dewpoint’s disease-agnostic approach.

Disease 98

Disease Small Molecule Cell Biology Medical Schools 98

Drug Discovery World

APRIL 5, 2023

Members contribute their expertise in high throughput screening, structural biology, medicinal chemistry, compound profiling, cancer cell biology, and in vivo and in vitro models for oncology.

Small Molecule 130

Small Molecule Cell Biology Laboratories Engineering 130

Drug Discovery World

JULY 11, 2023

The funding will support preclinical development, including development of a manufacturing process in collaboration with the Cell and Gene Therapy Catapult, whose mission is to support the UK’s cell and gene therapy industry.

Therapies 100

Therapies Cell Biology Engineering Production 100

Codon

AUGUST 10, 2023

Nature Reviews Molecular Cell Biology (2009). Link The second decade of synthetic biology: 2010–2020 , by Meng F. & Link Synthetic biology in mammalian cells: next generation research tools and therapeutics , by Lienert F. Nature Reviews Molecular Cell Biology (2014). . & Weiss R.

DNA 98

DNA Cell Biology Molecular Biology Engineering 98

Drug Discovery World

AUGUST 31, 2023

The researchers demonstrated that all the complex cells in the thymus epithelium could be produced from a single stem cell, highlighting a remarkable and yet untapped regenerative potential.

Research 147

Research Immune Response Cell Biology Laboratories 147

Drug Discovery World

SEPTEMBER 2, 2022

Read the original paper: ‘Eps15/Pan1p is a master regulator of the late stages of the endocytic pathway’ in the Journal of Cell Biology. It also has a crucial role in actin polymerisation and drives the recruitment of a range of actin nucleation promoting factors.

Cell Biology 130

Cell Biology Science Regulations Therapies 130

Chemical Biology and Drug Design

JULY 27, 2023

DDP-resistant NPC cells were established by treatment with DDP at increased concentrations (2, 4, 6, 8, or 10 μg/mL). Cell biological behaviors were assessed via cell function experiments. MicroRNA-577 and EIF5A2 mRNA expressions were detected by qRT-PCR.

Regulations 100

Regulations Cell Biology Treatment Research 100

Drug Discovery World

AUGUST 11, 2022

The partnership will combine MDC’s expertise in cell biology and drug discovery with ZEISS’ microscope instrumentation and image analysis capabilities. A new partnership has been formed between Medicines Discovery Catapult (MDC) and technology group ZEISS to improve drug discovery using advanced microscopy solutions. .

Cell Biology 130

Cell Biology Drugs Laboratories Disease 130

KIF1A

MARCH 2, 2024

Read the Article Rare Roundup The Jackson Laboratory offers “Exploring Rare Disease Through Translational Research” MiniCourse Human health is incredibly complex; developing safe, effective treatments requires knowledge of molecular mechanisms, cell biology, and drug administration.

Laboratories 119

Laboratories Cell Biology Disease Research 119

Broad Institute

DECEMBER 13, 2023

Hacohen Group, Cell Circuits Bhaavana Oruganty Swarthmore College Engineering (major), B.S., Chemistry (minor) Golub Lab, Cancer Program Ava Perry Texas A&M University Molecular and Cell Biology (major), B.S., Biochemistry (minor) Golub Lab, Cancer Program Alexander Rojas Emory University Biology B.S.

Molecular Biology 52

Molecular Biology Cell Biology Engineering Science 52

Drug Discovery World

JANUARY 19, 2023

Most only give an endpoint information, lyse the cells and have to be conducted in an environment or in conditions that are by no means close to in-vivo conditions. In addition, the techniques used are mostly far too expensive to be regularly affordable and accessible to the common researcher.

Treatment 130

Treatment Cell Biology Therapies Drugs 130

Broad Institute

FEBRUARY 29, 2024

Prior to joining the platform, Lipinski worked for almost five years as a postdoc with Paola Arlotta at Harvard Department of Stem Cell and Regenerative Biology and Stanley Center for Psychiatric Research. There, he used cortical organoid models of bipolar disorder to study patient response to lithium. Lipinski earned his Ph.D.

Cell Biology 52

Cell Biology Disease Science Research 52

Drug Target Review

NOVEMBER 17, 2023

Professor Alan Trounson AO CEO, Executive Director, Cartherics Alan is the past President of the Californian Institute for Regenerative Medicine (2007-2014), the Californian state’s $3 billion stem cell agency driving research in stem cell biology and facilitating the translation of stem cell discoveries into clinical therapies.

Therapies 117

Therapies Cell Biology Clinical Trials Trials 117

Codon

AUGUST 10, 2023

Nature Reviews Molecular Cell Biology (2009). Link The second decade of synthetic biology: 2010–2020 , by Meng F. & Link Synthetic biology in mammalian cells: next generation research tools and therapeutics , by Lienert F. Nature Reviews Molecular Cell Biology (2014). . & Weiss R.

DNA 52

DNA Cell Biology Engineering Molecular Biology 52

Drug Discovery World

APRIL 18, 2023

Riccardo Dalla-Favera, a Fellow of the AACR Academy, is Director of the Institute for Cancer Genetics; the Percy and Joanne Uris Professor of Clinical Medicine; Professor of Pathology and Cell Biology, Microbiology and Immunology, and Genetics and Development; and member of the Herbert Irving Comprehensive Cancer Center at Columbia University.

DNA 130

DNA Bioinformatics Cell Biology Clinical Trials 130

Drug Target Review

OCTOBER 16, 2023

Nikki drives adoption of 3D cellular models of human disease by applying her expertise in cell biology to drug discovery and high-throughput screening. About the author Nikki Carter Commercial Organoid Innovation Director, Molecular Devices. Nikki’s life sciences experience spans leadership, commercial and research roles.

Disease 121

Disease Immune Response Cell Biology Engineering 121

Drug Target Review

AUGUST 7, 2023

This paves the way for exploring ways to stimulate this machinery in aging cells, potentially offering new avenues for therapeutics. An ambitious research journey The interdisciplinary nature of this research, combining computational biology, immunology, cell biology, and biophysics, was instrumental in its success.

Disease 98

Disease Cell Biology Research Drugs 98

Drug Discovery World

JANUARY 26, 2023

Senior author Marcia Haigis, Professor of cell biology in the Blavatnik Institute at Harvard Medical School has been working in this area for 15 years. With further research, the team at Harvard Medical School hope that more targeted therapies can be developed to treat cancers whose growth is fuelled by this metabolite.

Medical Schools 130

Medical Schools Cell Biology Research Therapies 130

The Pharma Data

OCTOBER 27, 2021

million expansion will bring high quality seeds to worldwide markets faster, providing solutions for growers and meeting consumer demands / The seven-hectare global Product Design Center in San Nicolás includes state-of-the-art lab space for cell biology research and greenhouses for seed production.

Cell Biology 40

Cell Biology Production Laboratories Marketing 40

Drug Target Review

NOVEMBER 24, 2023

Achieving a mouse brain map has been made possible by advances in computing and data processing, as well as previous work by Lichtman and other researchers like Professor Florian Engert in molecular and cell biology, studying the brains of fruit flies and zebrafish.

Cell Biology 104

Cell Biology Engineering Research Treatment 104

Drug Discovery World

AUGUST 17, 2023

DDW Volume 24 – Issue 3, Summer 2023 Biography: Alok Javali gained his PhD from the Institute of Stem Cell Biology and Regenerative Medicine. He joined Nicolas Rvron’s lab in 2020, where he co-invented human blastoids; the model of early human embryos derived solely from stem cells.

Cell Biology 130

Cell Biology International Science Drug Development 130

Drug Target Review

APRIL 12, 2024

With its disruptive pipetting technology, SEED Biosciences is bridging the gap between the capabilities in liquid handling and the opportunities in single cell biology. He is the CEO and cofounder of SEED Biosciences Ltd, a spinoff from the EPFL.

Cell Biology 105

Cell Biology FDA Approval FDA Research 105

Drug Target Review

AUGUST 10, 2023

When bound to GRP78, ID2 loses its inhibitory function, leading to increased invasiveness of cancer cells. Implications for cancer therapeutics and beyond These findings have wide-ranging implications for cancer treatment and cell biology research.

Cell Biology 52

Cell Biology Small Molecule Regulations Engineering 52

The Pharma Data

MARCH 16, 2022

The research scientist at the Max Planck Institute for Medical Research received the award in recognition of his ground-breaking work in establishing various approaches to protein labeling in living cells that have enabled far-reaching advances in chemical and cell biology. Protein labeling (e.g.

Molecular Biology 52

Molecular Biology Cell Biology Science Laboratories 52

Drug Target Review

JUNE 5, 2023

Prior to joining Zymeworks, Paul served as Vice President, Cell Biology, and Immunology at MacroGenics, where he worked on the development of numerous clinical stage compounds and scientific collaborations with a range of pharmaceutical partners.

Treatment 100

Treatment Pharmacokinetics Cell Biology Drugs 100

Drug Discovery World

AUGUST 10, 2023

DDW Volume 24 – Issue 3, Summer 2023 Biography: Neil Dhawan is the Co-founder and CEO of Totus Medicines, where he focuses on combining small molecule design, structural biology, genetics, biochemistry, and cell biology to design new classes of drugs to target untreatable diseases.

Small Molecule 130

Small Molecule Clinical Trials Cell Biology Disease 130

Drug Target Review

APRIL 12, 2024

With its disruptive pipetting technology, SEED Biosciences is bridging the gap between the capabilities in liquid handling and the opportunities in single cell biology. He is the CEO and cofounder of SEED Biosciences Ltd , a spinoff from the EPFL.

Cell Biology 98

Cell Biology FDA Approval FDA Research 98

Drug Discovery World

OCTOBER 12, 2023

He says: “Through advances in genomics, single-cell biology and increasingly sophisticated analysis of large data sets, we are gaining a far greater understanding of human disease and how it varies and segments across the patient population.

Drugs 147

Drugs Science Cell Biology Therapies 147

Drug Target Review

JUNE 7, 2024

She has deep knowledge in Immunology and T cell biology, and 13 years of experience in Research (seven of them in biotech at Immunocore), including pipeline programme leadership. Dr Ribeiro holds a PhD in Biomedical Sciences from University of Porto, Portugal, studying T cell and thymus development.

Engineering 81

Engineering Clinical Trials Therapies Cell Biology 81

Drug Discovery World

OCTOBER 18, 2023

in Cell Biology and Biochemistry from University College London and was a post-doctoral fellow at Albert Einstein College of Medicine in New York City. She received a Ph.D. References 1: U.S. Food & Drug Administration (2017) FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss.

Therapies 162

Therapies Clinical Trials FDA Approval Virus 162

Drug Target Review

APRIL 9, 2024

Initial works from the lab concentrated on exploring the role of replicative stress in cancer and ageing, for which the group combined cell biology, mouse models and drug development projects. In 2005, he joined CNIO to lead the Genomic Instability Group where he has been ever since.

RNA 63

RNA Cell Biology Clinical Development DNA 63